Where the stock stands
Anupam Rasayan India Ltd., a Chemicals sector company, closed at 1263.8 on 14 July 2026, with a modest 0.4 percent gain in the latest session to 1268.9. The stock trades 10.69 percent below its 52-week high of 1415.0 and 20.91 percent above its 52-week low of 1045.2. Over the past year, it has delivered a return of 10.79 percent, though recent momentum has weakened — down 0.58 percent over one week, 0.45 percent over one month, and 1.86 percent over three months. The company commands a market capitalisation of 14,479 crore, with a price-to-earnings ratio of 82.8 and price-to-book of 4.34. Return on equity stands at 5.8 percent, and the dividend yield is 0.12 percent. The data shows no information on earnings growth trends or debt levels.
What the smart-money flow shows
The evidence pack contains no futures and options positioning data, no named bulk or block deals, no institutional holding streaks, and no recent insider transaction filings. Relative volume at 3.11 indicates trading activity roughly three times the average, but the data does not establish whether this reflects institutional accumulation, distribution, or retail participation. The 9-day-old headline from Sahi reports that Tanfac Industries secured a 173.5 crore capital injection from promoter Anupam Rasayan at 2,341 per share — a significant premium to the current market price — though this describes a related-party transaction rather than open-market activity. Without F&O data, institutional flow metrics, or promoter buying/selling records, the smart-money picture remains incomplete.
The technical picture
The RSI-14 reading of 41.8 places the stock in neutral territory, neither oversold nor overbought. Price action shows mixed trend signals: the stock sits below its 50-day simple moving average but remains above its 200-day simple moving average, suggesting intermediate-term softness within a longer-term uptrend. Neither a golden cross nor death cross is active. The 10.69 percent drawdown from the 52-week high indicates the stock has given back a portion of its yearly gains, while the 20.91 percent cushion above the 52-week low shows it has not retested crisis levels. The elevated relative volume of 3.11 warrants attention, though without accompanying price direction or positioning data, its interpretation is limited.
Catalysts and what to watch
The most recent catalyst is a 15 July 2026 NSE disclosure announcing a Letter of Intent with BASQUEVOLT, S.A. for potential long-term supply of a specialty chemical product worth 300 million dollars — flagged as bullish in the evidence pack. According to a headline from CNBC TV18 from 33 days ago, the company had become the first to commercialise ETFA and was eyeing a 500 million dollar market. A 33-day-old ALCHEMPro headline also referenced this commercialisation via flow technology. The data shows no scheduled earnings announcements, analyst rating changes, or regulatory filings. What the data establishes: a large prospective order, a history of product innovation, and elevated trading interest. What it does not establish: whether the BASQUEVOLT agreement will convert to firm orders, the margin profile of any new business, institutional positioning, or near-term earnings trajectory.